With the advent of molecular analyses, missense mutation in codon 209 of the GNAQ gene was defined as a pathognomonic mutation in CNS melanocytic tumors [6]; thus, the recent WHO 2021 classification of CNS tumors took into account histological and molecular features for the classification of CNS melanocytic tumors [7]. Here, GNAQ is linked to central nervous system melanocytic neoplasm.